Literature DB >> 23037956

Asymmetric catalysis based on tropos ligands.

Kohsuke Aikawa1, Koichi Mikami.   

Abstract

All enantiopure atropisomeric (atropos) ligands essentially require enantiomeric resolution or synthetic transformation from a chiral pool. In sharp contrast, the use of tropos (chirally flexible) ligands, which are highly modular, versatile, and easy to synthesize without enantiomeric resolution, has recently been the topic of much interest in asymmetric catalysis. Racemic catalysts bearing tropos ligands can be applied to asymmetric catalysis through enantiomeric discrimination by the addition of a chiral source, which preferentially transforms one catalyst enantiomer into a highly activated catalyst enantiomer. Additionally, racemic catalysts bearing tropos ligands can also be utilized as atropos enantiopure catalysts obtained via the control of chirality by a chiral source followed by the memory of chirality. In this feature article, our results on the asymmetric catalysis via the combination of various central metals and tropos ligands are summarized.

Year:  2012        PMID: 23037956     DOI: 10.1039/c2cc34320g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  Bicyclic Phenyl-Ethynyl Architectures: Synthesis of a 1,4-Bis(phenylbuta-1,3-diyn-1-yl) Benzene Banister.

Authors:  Linda Maria Bannwart; Thomas Müntener; Michel Rickhaus; Lukas Jundt; Daniel Häussinger; Marcel Mayor
Journal:  Chemistry       Date:  2021-03-03       Impact factor: 5.236

2.  Dynamic Stereochemistry of a Biphenyl-Bisprolineamide Model Catalyst and its Imidazolidinone Intermediates.

Authors:  Tino P Golub; Malte Feßner; Elric Engelage; Christian Merten
Journal:  Chemistry       Date:  2022-06-23       Impact factor: 5.020

3.  Enantiodivergent asymmetric catalysis with the tropos BIPHEP ligand and a proline derivative as chiral selector.

Authors:  P Oczipka; D Müller; W Leitner; G Franciò
Journal:  Chem Sci       Date:  2015-10-29       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.